Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays

In the United States (U.S.), a hepatitis E virus (HEV) seroprevalence between 6 and 21% has been described, with a decreasing trend. We aimed to investigate HEV infection in the U.S. population from 2009 to 2016, and examine the differences in seroprevalence using different assays. We used data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisano, María Belén, Campbell, Christopher, Anugwom, Chimaobi, Ré, Viviana Elizabeth, Debes, José D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355204/
https://www.ncbi.nlm.nih.gov/pubmed/35930611
http://dx.doi.org/10.1371/journal.pone.0272809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355204/
https://www.ncbi.nlm.nih.gov/pubmed/35930611
http://dx.doi.org/10.1371/journal.pone.0272809

Ejemplares similares